As artificial intelligence rapidly embeds itself across pharmaceutical manufacturing, R&D, and quality systems, it is no longer just driving efficiency, it is exposing a critical divide in digital maturity. Across GMP-regulated environments, AI is revealing hidden weaknesses in data integrity,